Post Hoc Analyses of Responder Status in Phase 3 Studies of Ciliary Neurotrophic Factor–Producing Revakinagene Taroretcel in People With Macular Telangiectasia Type 2

• John A. Wells, MD, FACS

• Video
• Published 2024

See more

• Updates from the Field
• John A. Wells, MD, FACS